Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transgenic Organisms00:53

Transgenic Organisms

Overview
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dopamine replacement therapy modulates DDC, prolactin and AOC3 levels in Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: <i>In vitro</i> and <i>in vivo</i> insights into therapeutic targeting.

iScience·2026
Same author

Reactive astrocytes mediate toxicity in iPSC derived dopaminergic neurons.

NPJ Parkinson's disease·2026
Same author

Synthetic nanoparticles for cell-type specific, spatially resolved loading and export of MiRNAs in neural cells.

Journal of nanobiotechnology·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

The G2019S LRRK2 mutation exacerbates α-synuclein and tau neuropathology through divergent pathways in Parkinson's disease models.

Acta neuropathologica·2025

Related Experiment Video

Updated: Jun 3, 2026

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX
10:09

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX

Published on: June 27, 2017

Developing extrachromosomal gene expression vector technologies: an overview.

Richard Wade-Martins1

  • 1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. richard.wade-martins@dpag.ox.ac.uk

Methods in Molecular Biology (Clifton, N.J.)
|March 25, 2011
PubMed
Summary

Extrachromosomal vectors offer safer, more stable gene delivery than integrating vectors. These episomal vectors avoid genotoxicity and position effects, enabling high-capacity, physiologically regulated transgene expression for therapeutic applications.

More Related Videos

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1&#945; Promoter Using Gibson Assembly
10:18

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1α Promoter Using Gibson Assembly

Published on: February 9, 2015

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness
06:21

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness

Published on: May 7, 2018

Related Experiment Videos

Last Updated: Jun 3, 2026

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX
10:09

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX

Published on: June 27, 2017

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1&#945; Promoter Using Gibson Assembly
10:18

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1α Promoter Using Gibson Assembly

Published on: February 9, 2015

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness
06:21

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness

Published on: May 7, 2018

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Integrating vectors raise safety concerns due to genotoxicity and position effects.
  • Extrachromosomal (episomal) vectors offer an alternative with distinct advantages.

Purpose of the Study:

  • To review the benefits of episomal vectors over integrating vectors.
  • To outline potential therapeutic and scientific applications of episomal vectors.

Main Methods:

  • Discussion of episomal vector characteristics, including persistence, capacity, and regulation.
  • Comparison of episomal vectors with integrating vectors regarding safety and expression.

Main Results:

  • Episomal vectors persist in the nucleus without integrating into the host genome.
  • They avoid genotoxicity, vector rearrangement, and position effects associated with integration.
  • High transgene capacity allows for large regulatory elements or genomic loci delivery.
  • Genomic locus delivery enables physiological and developmental-stage gene regulation.

Conclusions:

  • Episomal vectors provide prolonged transgene persistence and expression without integration.
  • Their high capacity and ability to deliver genomic DNA facilitate advanced gene therapy strategies.
  • Potential applications span various therapeutic and scientific fields, offering a safer alternative to integrating vectors.